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Periodontal disease is a chronic condition characterized by an opportunistic infec-
tion of the periodontal tissues by Gram- anaerobic bacteria (1). Tissue destruction 
can be limited by the production of anti-inflammatory substances and its final entity 
depends on the equilibrium between pro- and anti-inflammatory mechanisms. The 
endocannabinoid system (EC) is supposed to have an anti-inflammatory action. The 
two most extensively studied molecules of the EC are anandamide and 2-AG with 
their specific receptors, CB1 and CB2. Nakajima et al (2) showed the presence of CB1 
and CB2 receptors in human gingival fibroblasts from healthy patients and subjects 
affected by periodontal inflammation and found that AEA significantly reduced the 
production of cytokines (IL-6, IL-8 and MCP-1) by gingival fibroblasts after bacteria 
stimulation, through CB1 and CB2 receptors. The aim of this project was to quanti-
tatively and qualitatively evaluate the presence of CB1 and CB2 receptors in the gin-
gival tissue from patients affected by periodontitis compared to healthy subjects. Ten 
patients were recruited, six healthy subjects (H) and four with chronic periodontitis 
(P). In each patient, a gingival biopsy was harvested during periodontal treatment 
and processed for immunohistochemistry to reveal CB1 and CB2 expression. Every 
sample was mapped at 200X total magnification and the presence of CB1 and CB2 
was quantified using a standardized method with Adobe Photoshop PS5. The per-
centage of marked tissue in the connective tissue and in the epithelium was calculat-
ed. In P the mean CB1 percentage on the connective tissue (CB1-c) was 2.27% + 0.14% 
and CB2 (CN2-c) was 2.12% + 0.43%, while in H the values were 0.13% + 0.31% and 
0.06% + 0.11% respectively. In P the mean CB1 value on the epithelium (CB1-e) was 
5.08 + 2.27% and CB2 (CB2-e) was 4.07% + 1.64%, while in H the corresponding val-
ues were respectively 0.16% + 0.36% and 0.03% + 0.02%. CB1 and CB2 expression 
resulted significantly higher in P than in H samples in both epithelial and connective 
tissue (Wilcoxon sum rank test, p<0.01). Such data confirm that EC are involved in 
periodontal disease.
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